Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.

Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, Smith AW, Alfano CM, McTiernan A, Ballard-Barbash R, Bernstein L.

Breast Cancer Res. 2014 Aug 22;16(4):414. doi: 10.1186/s13058-014-0414-x.

2.

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women.

Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, Bernstein L.

Breast Cancer Res Treat. 2009 Jan;113(2):383-91. doi: 10.1007/s10549-008-9940-5.

PMID:
18297429
3.

Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?

Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG.

Breast Cancer Res Treat. 2013 Aug;140(3):485-94. doi: 10.1007/s10549-013-2655-2.

4.

Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors.

Das N, Baumgartner RN, Riley EC, Pinkston CM, Yang D, Baumgartner KB.

J Cancer Surviv. 2015 Sep;9(3):422-30. doi: 10.1007/s11764-014-0416-9.

PMID:
25913877
5.

The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.

Rebegea L, Firescu D, Dumitru M, Anghel R.

Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7.

6.

The epidemiology of arm and hand swelling in premenopausal breast cancer survivors.

Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775-82.

7.

Risk factors for lymphedema after breast cancer treatment.

Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46. doi: 10.1158/1055-9965.EPI-09-1245.

8.

Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.

Helyer LK, Varnic M, Le LW, Leong W, McCready D.

Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x.

PMID:
19889169
9.

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.

Ahmed RL, Schmitz KH, Prizment AE, Folsom AR.

Breast Cancer Res Treat. 2011 Dec;130(3):981-91. doi: 10.1007/s10549-011-1667-z.

10.

Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.

Nesvold IL, Dahl AA, L√łkkevik E, Marit Mengshoel A, Foss√• SD.

Acta Oncol. 2008;47(5):835-42. doi: 10.1080/02841860801961257.

PMID:
18568481
11.

Risk factors associated with breast cancer-related lymphedema in the WHEL Study.

Dominick SA, Madlensky L, Natarajan L, Pierce JP.

J Cancer Surviv. 2013 Mar;7(1):115-23. doi: 10.1007/s11764-012-0251-9.

12.

Immediate Implant Reconstruction Is Associated With a Reduced Risk of Lymphedema Compared to Mastectomy Alone: A Prospective Cohort Study.

Miller CL, Colwell AS, Horick N, Skolny MN, Jammallo LS, O'Toole JA, Shenouda MN, Sadek BT, Swaroop MN, Ferguson CM, Smith BL, Specht MC, Taghian AG.

Ann Surg. 2016 Feb;263(2):399-405. doi: 10.1097/SLA.0000000000001128.

PMID:
25607768
13.

Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.

Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH.

Arch Surg. 2010 Nov;145(11):1055-63. doi: 10.1001/archsurg.2010.231.

14.

Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort.

Swaroop MN, Ferguson CM, Horick NK, Skolny MN, Miller CL, Jammallo LS, Brunelle CL, O'Toole JA, Isakoff SJ, Specht MC, Taghian AG.

Breast Cancer Res Treat. 2015 Jun;151(2):393-403. doi: 10.1007/s10549-015-3408-1.

15.

Breast cancer related lymphedema in patients with different loco-regional treatments.

Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V.

Breast. 2012 Jun;21(3):361-5. doi: 10.1016/j.breast.2012.03.002.

PMID:
22460058
16.

The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.

Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C.

Ann Surg Oncol. 2009 Jul;16(7):1959-72. doi: 10.1245/s10434-009-0452-2.

PMID:
19365624
17.

Lymphedema and quality of life in survivors of early-stage breast cancer.

Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT.

Arch Surg. 2002 Nov;137(11):1253-7.

PMID:
12413312
18.

The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study.

Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, Shenouda MN, O'Toole JA, MacDonald SM, Specht MC, Taghian AG.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):565-71. doi: 10.1016/j.ijrobp.2013.11.232.

19.

Determinants of newly diagnosed comorbidities among breast cancer survivors.

Obi N, Gornyk D, Heinz J, Vrieling A, Seibold P, Chang-Claude J, Flesch-Janys D.

J Cancer Surviv. 2014 Sep;8(3):384-93. doi: 10.1007/s11764-013-0338-y.

PMID:
24570215
20.

Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone.

Card A, Crosby MA, Liu J, Lindstrom WA, Lucci A, Chang DW.

Plast Reconstr Surg. 2012 Dec;130(6):1169-78. doi: 10.1097/PRS.0b013e31826d0faa.

PMID:
22878475
Items per page

Supplemental Content

Support Center